Neuroprotection in Autism Schizophrenia and Alzheimer s disease

Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease provides an up-to-date overview on recent clinical studies and the similarities discovered in the most prevalent brain disorders. The book's content will help shed light on basic mechanisms and provide new avenues for early diagnosis toward disease prevention and disease modification. It is written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry. Sections discuss the shared pathophysiological mechanisms that underlie autism, schizophrenia/mood disorders and Alzheimer’s disease, i.e. neurodevelopmental disorders, neuropsychiatric diseases and neurodegenerative disorders. Offers an up-to-date overview of basic and clinical studies concerning similarities in the most prevalent brain disorders Helps the reader become familiar with novel neuroprotective mechanisms and experimental treatment modalities in these difficult to treat disorders Written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry

Produk Detail:

  • Author : Illana Gozes
  • Publisher : Academic Press
  • Pages : 322 pages
  • ISBN : 0128140380
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKNeuroprotection in Autism Schizophrenia and Alzheimer s disease

Neuroprotection in Autism, Schizophrenia and Alzheimer's disease

Neuroprotection in Autism, Schizophrenia and Alzheimer's disease
  • Author : Illana Gozes,Joseph Levine
  • Publisher : Academic Press
  • Release : 16 October 2019
GET THIS BOOKNeuroprotection in Autism, Schizophrenia and Alzheimer's disease

Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease provides an up-to-date overview on recent clinical studies and the similarities discovered in the most prevalent brain disorders. The book's content will help shed light on basic mechanisms and provide new avenues for early diagnosis toward disease prevention and disease modification. It is written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry. Sections discuss the shared pathophysiological mechanisms that underlie autism, schizophrenia/mood disorders and Alzheimer’s disease, i.e.

Neuroprotection in Alzheimer's Disease

Neuroprotection in Alzheimer's Disease
  • Author : Illana Gozes
  • Publisher : Academic Press
  • Release : 30 December 2016
GET THIS BOOKNeuroprotection in Alzheimer's Disease

Neuroprotection in Alzheimer’s Disease offers a translational point-of-view from both basic and clinical standpoints, putting it on the cusp for further clinical development with its emphasis on nerve cell protection, including the accumulation of knowledge from failed clinical trials and new advances in disease management. This book brings together the latest findings, both basic, and clinical, under the same cover, making it easy for the reader to obtain a complete overview of the state-of-the-field and beyond. Alzheimer's disease is

Marine Anti-inflammatory Agents 2020

Marine Anti-inflammatory Agents 2020
  • Author : Donatella Degl’Innocenti,Marzia Vasarri
  • Publisher : MDPI
  • Release : 18 May 2021
GET THIS BOOKMarine Anti-inflammatory Agents 2020

This Special Issue covers original and innovative basic research regarding the anti-inflammatory potential of several classes of secondary metabolites (i.e., polyphenols, phytosterols, proteoglycans, and polysaccharides) in manifestations of acute and chronic inflammation in both in vitro and in vivo experimental models.

Handbook of Research on Critical Issues in Special Education for School Rehabilitation Practices

Handbook of Research on Critical Issues in Special Education for School Rehabilitation Practices
  • Author : Singh, Ajay,Yeh, Chia Jung,Blanchard, Sheresa,Anunciação, Luis
  • Publisher : IGI Global
  • Release : 23 April 2021
GET THIS BOOKHandbook of Research on Critical Issues in Special Education for School Rehabilitation Practices

Rehabilitation professionals working with students with disabilities and the families of those students face unique challenges in providing inclusive services to special education student populations. There needs to be a focus on adaptive teaching methods that provide quality experience for students with varying disabilities to promote student success and inclusivity. Critical issues within these practices span autism, diverse students, gifted education, learning disabilities, behavioral and emotional disorders, and more. With having many different types of students with vastly different situations,

Periodontitis

Periodontitis
  • Author : Julien Santi-Rocca
  • Publisher : Springer Nature
  • Release : 26 June 2022
GET THIS BOOKPeriodontitis

Periodontitis is a disease that affects more than half the adult population in the world. Treatment is often based on ancient recommendations consisting in mechanically removing material from damaged zones. However, novel therapeutic management strategies exist, from prevention to efficient treatment, and regeneration. The need of integrative approaches to circumvent this worldwide pledge can be achieved through: A better understanding of this complex disease by promoting scientific research and a comprehensive multidisciplinary approach, including epidemiology, microbiology, immunology, physiology, therapeutics, psychology,

Handbook of Neuroemergency Clinical Trials

Handbook of Neuroemergency Clinical Trials
  • Author : Brett E. Skolnick,Wayne M. Alves
  • Publisher : Academic Press
  • Release : 13 November 2017
GET THIS BOOKHandbook of Neuroemergency Clinical Trials

Handbook of Neuroemergency Clinical Trials, Second Edition, focuses on the practice of clinical trials in acute neuroscience populations, or what have been called neuroemergencies. Neuroemergencies are complex, life-threatening diseases and disorders, often with devastating consequences, including death or disability. The overall costs are staggering in terms of annual incidence and costs associated with treatment and survival, yet despite their significance as public health issues, there are few drugs and devices available for definitive treatment. The book focuses on novel therapies

Brain Protection in Schizophrenia, Mood and Cognitive Disorders

Brain Protection in Schizophrenia, Mood and Cognitive Disorders
  • Author : Michael S. Ritsner
  • Publisher : Springer Science & Business Media
  • Release : 16 June 2010
GET THIS BOOKBrain Protection in Schizophrenia, Mood and Cognitive Disorders

Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to

Photobiomodulation in the Brain

Photobiomodulation in the Brain
  • Author : Michael R. Hamblin,Ying-Ying Huang
  • Publisher : Academic Press
  • Release : 13 July 2019
GET THIS BOOKPhotobiomodulation in the Brain

Photobiomodulation in the Brain: Low-Level Laser (Light) Therapy in Neurology and Neuroscience presents the fundamentals of photobiomodulation and the diversity of applications in which light can be implemented in the brain. It will serve as a reference for future research in the area, providing the basic foundations readers need to understand photobiomodulation’s science-based evidence, practical applications and related adaptations to specific therapeutic interventions. The book covers the mechanisms of action of photobiomodulation to the brain, and includes chapters describing

Evidence-informed Approaches for Managing Dementia Transitions

Evidence-informed Approaches for Managing Dementia Transitions
  • Author : Linda Garcia,Lynn McCleary,Neil Drummond
  • Publisher : Academic Press
  • Release : 02 February 2020
GET THIS BOOKEvidence-informed Approaches for Managing Dementia Transitions

Evidence-Informed Approaches for Managing Dementia Transitions provides evidence-informed approaches and future directions for supporting a higher quality of life for people living with dementia. Through a person-centered lens, this book equips care providers to better help people living with dementia align their expectations and hopes with the trajectories they can expect in their journey. It highlights the various transitions that those with dementia will experience and describes best practices for optimal adjustment to each. Topics covered include problem identification, driving

Neurobiology of Brain Disorders

Neurobiology of Brain Disorders
  • Author : Michael J. Zigmond,Clayton A. Wiley,Marie-Francoise Chesselet
  • Publisher : Academic Press
  • Release : 27 May 2022
GET THIS BOOKNeurobiology of Brain Disorders

Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders, Second Edition provides basic scientists a comprehensive overview of neurological and neuropsychiatric disease. This book links basic, translational, and clinical research, covering the genetic, developmental, molecular and cellular mechanisms underlying all major categories of brain disorders. It offers students, postdoctoral fellows, and researchers in diverse fields of neuroscience, neurobiology, neurology, and psychiatry the tools they need to obtain a basic background in the major neurological and psychiatric diseases. Topics

The Health Effects of Cannabis and Cannabinoids

The Health Effects of Cannabis and Cannabinoids
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Population Health and Public Health Practice,Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda
  • Publisher : National Academies Press
  • Release : 31 March 2017
GET THIS BOOKThe Health Effects of Cannabis and Cannabinoids

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the